Menu
Live News EQUITY M impact

CervoMed receives US patent allowance for neflamapimod use in Lewy body dementia

CervoMed receives US patent allowance for neflamapimod use in Lewy body dementia

SPYQQQESNQ

CervoMed receives US patent allowance for neflamapimod use in Lewy body dementia